Pfizer standalone net profit rises 56.91% in the March 2016 quarter

Sales rise 11.58% to Rs 509.15 crore

Net profit of Pfizer rose 56.91% to Rs 66.97 crore in the quarter ended March 2016 as against Rs 42.68 crore during the previous quarter ended March 2015. Sales rose 11.58% to Rs 509.15 crore in the quarter ended March 2016 as against Rs 456.31 crore during the previous quarter ended March 2015.

For the full year,net profit rose 219.08% to Rs 222.78 crore in the year ended March 2016 as against Rs 69.82 crore during the previous year ended March 2015. Sales rose 9.14% to Rs 1994.86 crore in the year ended March 2016 as against Rs 1827.74 crore during the previous year ended March 2015.

ParticularsQuarter EndedYear EndedMar. 2016Mar. 2015% Var.Mar. 2016Mar. 2015% Var.Sales509.15456.31 12 1994.861827.74 9 OPM %24.1627.35 -21.6020.95 - PBDT151.31143.38 6 516.20537.47 -4 PBT119.55109.74 9 392.33287.95 36 NP66.9742.68 57 222.7869.82 219

Powered by Capital Market - Live News